VALGANCICLOVIR HYDROCHLORIDE (McKesson Corporation)
Welcome to the PulseAid listing for the VALGANCICLOVIR HYDROCHLORIDE drug offered from McKesson Corporation. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | McKesson Corporation |
NON-PROPRIETARY NAME: | VALGANCICLOVIR HYDROCHLORIDE |
SUBSTANCE NAME: | VALGANCICLOVIR HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-03-31 |
END MARKETING DATE: | 0000-00-00 |
VALGANCICLOVIR HYDROCHLORIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | VALGANCICLOVIR HYDROCHLORIDE from McKesson Corporation |
LABELER NAME: | McKesson Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 450(mg/1) |
START MARKETING DATE: | 2016-03-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63739-357_e937f02d-a76c-4a2f-b9ad-84897391580f |
PRODUCT NDC: | 63739-357 |
APPLICATION NUMBER: | ANDA204750 |
Other VALGANCICLOVIR HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: